Piperacillin and Tazobactam
These highlights do not include all the information needed to use Piperacillin and Tazobactam for Injection safely and effectively. See full prescribing information for Piperacillin and Tazobactam for Injection. PIPERACILLIN AND TAZOBACTAM FOR INJECTION: single-dose vials Initial U.S. Approval: 1993 To reduce the development of drug-resistant bacteria and maintain the effectiveness of Piperacillin and Tazobactam for Injection and other antibacterial drugs, Piperacillin and Tazobactam for Injection should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.
ba87ade3-4d41-40c0-9f6a-27e121a4136d
HUMAN PRESCRIPTION DRUG LABEL
Dec 31, 2019
Fresenius Kabi USA, LLC
DUNS: 608775388
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
PIPERACILLIN SODIUM,TAZOBACTAM SODIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (2)
PIPERACILLIN SODIUM,TAZOBACTAM SODIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (2)
PIPERACILLIN SODIUM,TAZOBACTAM SODIUM
Product Details
FDA regulatory identification and product classification information